female scientist inspecting beaker

Research & Guidelines

ASCO advances clinical research through scientific meetings, educational programs, and peer-reviewed journals designed to help translate research results into quality care.

  • New CancerLinQ Discovery® Research Platform

    ASCO’s recently launched a new platform for CancerLinQ Discovery®, its de-identified real-world cancer data product for researchers across the cancer community. The new CancerLinQ Discovery Research Platform offers researchers a variety of new tools and capabilities.

    Learn More
  • New Hereditary Breast Cancer Guideline

    ASCO, American Society for Radiation Oncology (ASTRO) and Society of Surgical Oncology (SSO) has issued a new joint guideline on Management of Hereditary Breast Cancer. This guideline provides recommendations for BRCA1/2 and moderate penetrance genes.

    Now Available
  • New Head and Neck Practice Guideline

    ASCO issues new practice guideline on the Diagnosis and Management of Squamous Cell Carcinoma of Unknown Primary in the Head and Neck that describes preoperative evaluation for patients with a neck mass, surgical diagnostic and therapeutic procedures, and other approaches.

    Learn More
  • New Melanoma Guideline

    ASCO issues a new guideline on Systemic Therapy for Melanoma, recommendations include the use of targeted and immunotherapies.

    Learn More

Random Quote

"ASCO is leading the move to a new data-driven era of discovery in clinical oncology."
Peter Paul Yu, MD, FACP, FASCO
ASCO President, 2014-15